Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Aug 2010 - Proc. Natl. Acad. Sci. U.S.A.; 107(31):1091-6490 [PMID:20631300] [Van Tendeloo VF] [Van de Velde A] [Van Driessche A] [Cools N] [Anguille S] [Ladell K] [Gostick E] [Vermeulen K] [Pieters K] [Nijs G] [Stein B] [Smits EL] [Schroyens WA] [Gadisseur AP] [Vrelust I] [Jorens PG] [Goossens H] [de Vries IJ] [Price DA] [Oji Y] [Oka Y] [Sugiyama H] [Berneman ZN]
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response. Aug 2009 - Cancer Immunol. Immunother.; 58(10):1432-0851 [PMID:19225777] [Delluc S] [Hachem P] [Rusakiewicz S] [Gaston A] [Marchiol-Fournigault C] [Tourneur L] [Babchia N] [Fradelizi D] [Regnault A] [Sang KH] [Chiocchia G] [Buzyn A]
The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience. Jun 2009 - Pathol. Oncol. Res.; 15(2):1219-4956 [PMID:18807213] [Bagheri K] [Alimoghadam K] [Pourfathollah AA] [Hassan ZM] [Hajati J] [Moazzeni SM]
Immunotherapy of acute myeloid leukemia: current approaches. Apr 2009 - Oncologist; 14(3):1549-490X [PMID:19289488] [Smits EL] [Berneman ZN] [Van Tendeloo VF]
Immunotherapy in acute leukemia. Jan 2009 - Semin. Hematol.; 46(1):0037-1963 [PMID:19100371] [Leung W]
New therapeutic strategies in acute lymphoblastic leukemia. Jan 2009 - Semin. Hematol.; 46(1):0037-1963 [PMID:19100370] [Jeha S]
Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications. Dec 2008 - Handb Exp Pharmacol(188):0171-2004 [PMID:19031033] [van de Loosdrecht AA] [van den Ancker W] [Houtenbos I] [Ossenkoppele GJ] [Westers TM]
Dendritic cell vaccines in acute leukaemia. Oct 2008 - Best Pract Res Clin Haematol; 21(3):1521-6926 [PMID:18790453] [Duncan C] [Roddie H]
Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Jun 2008 - Transfusion; 48(5):0041-1132 [PMID:18208411] [Schmitt A] [Li L] [Giannopoulos K] [Greiner J] [Reinhardt P] [Wiesneth M] [Schmitt M]
Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia. Apr 2008 - Am. J. Hematol.; 83(4):1096-8652 [PMID:18081032] [Kitawaki T] [Kadowaki N] [Kondo T] [Ishikawa T] [Ichinohe T] [Teramukai S] [Fukushima M] [Kasai Y] [Maekawa T] [Uchiyama T]
Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy. Mar 2008 - Exp. Hematol.; 36(3):0301-472X [PMID:18207305] [Royer PJ] [Bougras G] [Ebstein F] [Leveque L] [Tanguy-Royer S] [Simon T] [Juge-Morineau N] [Chevallier P] [Harousseau JL] [Gregoire M]
Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia. Sep 2007 - Transfusion; 47(9):0041-1132 [PMID:17725721] [Schmitt A] [Reinhardt P] [Hus I] [Tabarkiewicz J] [Roliñski J] [Barth T] [Giannopoulos K] [Dmoszyñska A] [Wiesneth M] [Schmitt M]
Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia. Sep 2007 - Biomed. Pharmacother.; 61(6):0753-3322 [PMID:17368821] [Westers TM] [Ossenkoppele GJ] [van de Loosdrecht AA]
Dendritic cell vaccines for leukemia patients. Apr 2007 - Expert Rev Anticancer Ther; 7(3):1744-8328 [PMID:17338648] [Schmitt A] [Hus I] [Schmitt M]
Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Jan 2007 - J Clin Apher; 21(4):0733-2459 [PMID:17120232] [Choi BH] [Kang HK] [Park JS] [Kim SK] [Pham TN] [Zhu XW] [Cho D] [Nam JH] [Chung IJ] [Kim YJ] [Rhee JH] [Kim HJ] [Lee JJ]
